Organogenesis Holdings Inc (NASDAQ:ORGO) price on current trading day, rose 72.31% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.29.
A look at the stock’s price movement, the level at last check in today’s session was $3.07. Turning to its 52-week performance, $4.57 and $2.16 were the 52-week high and 52-week low respectively. Overall, ORGO moved 39.21% over the past month.
Organogenesis Holdings Inc’s market cap currently stands at around $665.09 million, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 93.8M for the company’s revenue for the quarter, with a low and high estimate of 93.8M and 93.8M respectively. The average forecast suggests down to a -14.71% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 470.81M, representing a -2.33% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ORGO is a 100% Buy. On the other hand, the stock is on average a 75% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend ORGO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ORGO’s current price about 48.66% and 55.39% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 77.42, while 7-day volatility ratio is 5.76% and 4.69% in the 30-day chart. Further, Organogenesis Holdings Inc (ORGO) has a beta value of 1.82, and an average true range (ATR) of 0.35. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is 5.48% off recent price level in today’s trading while to achieve the yearly target high, it has to move 5.48%. Nonetheless, investors will most likely welcome a 5.48% jump to $5 which is the analysts’ median price.
If we refocus on Organogenesis Holdings Inc (NASDAQ:ORGO), historical trading data shows that trading volumes averaged 630.45K over the past 3 months. The company’s latest data on shares outstanding shows there are 132.58 million shares.
The 49.26% of Organogenesis Holdings Inc’s shares are in the hands of company insiders while institutional holders own 49.89% of the company’s shares. Current price change has pushed the stock 65.31% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ORGO stock continues to rise going into the next quarter.
